학술논문

T108. AUT00206, A NOVEL KV3 CHANNEL MODULATOR, REDUCES KETAMINE-INDUCED BOLD SIGNALLING IN HEALTHY MALE VOLUNTEERS: A RANDOMISED PLACEBO-CONTROLLED CROSSOVER TRIAL.
Document Type
Article
Source
Schizophrenia Bulletin; 2019 Supplement 2, Vol. 45, pS245-S246, 2p
Subject
DRUG therapy for schizophrenia
DRUG efficacy
CONFERENCES & conventions
CELLULAR signal transduction
POTASSIUM antagonists
PHARMACODYNAMICS
Language
ISSN
05867614
Abstract
Copyright of Schizophrenia Bulletin is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)